NeoGenomics, Inc. Share Price Today: Live Updates & Key Insights

NeoGenomics, Inc. share price today is $8.11, up -2.69%. The stock opened at $8.15 against the previous close of $8.18, with an intraday high of $8.23 and low of $7.875.

NeoGenomics, Inc. Share Price Chart

NeoGenomics, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

NeoGenomics, Inc. Share Price Performance

$8.11 -0.0269(-2.69%) NEO at 23 Mar 2026 02:26 PM Diagnostics & Research
Lowest Today 7.875
Highest Today 8.23
Today’s Open 8.15
Prev. Close 8.18
52 Week High 13.74
52 Week Low 4.72
Day’s Range: Low 7.875 High 8.23
52-Week Range: Low 4.72 High 13.74
1 day return -
1 Week return -3.4
1 month return -20.3
3 month return -36.04
6 month return -5.52
1 year return -21.75
3 year return -56.07
5 year return -84.38
10 year return -

NeoGenomics, Inc. Institutional Holdings

BlackRock Inc 14.87

Vanguard Group Inc 10.65

First Light Asset Management, LLC 7.73

Greenhouse Funds LLLP 6.66

iShares Core S&P Small-Cap ETF 6.06

First Trust NYSE Arca Biotech ETF 4.76

D. E. Shaw & Co LP 4.08

Millennium Management LLC 4.01

State Street Corp 3.87

BRAIDWELL LP 3.57

Vanguard Total Stock Mkt Idx Inv 3.14

Schroder Investment Management Group 3.09

Geode Capital Management, LLC 2.45

iShares Russell 2000 ETF 2.42

Vanguard Small Cap Index 2.26

Nomura Small Cap Core I 2.22

Morgan Stanley - Brokerage Accounts 2.05

Macquarie Group Ltd 1.96

Driehaus Capital Management LLC 1.90

Dimensional Fund Advisors, Inc. 1.89

American Capital Management Inc 1.79

GW&K Investment Management, LLC 1.72

Partner Fund Management LP 1.70

The Goldman Sachs Group Inc 1.39

Aberdeen Group PLC 1.39

Segall Bryant & Hamill 1.33

Vanguard Small Cap Growth Index Inv 1.26

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Fidelity Small Cap Index 0.98

Glenmede Small Cap Equity 0.97

Glenmede Small Cap Equity Adv 0.97

State Street SPDR Port S&P 600 Sm CpETF 0.93

T. Rowe Price Small-Cap Value 0.90

abrdn Healthcare Opportunities 0.78

iShares Russell 2000 Value ETF 0.77

UWS Schroder US Mid Cap B 0.71

Vanguard Tax-Managed Small Cap Adm 0.70

Schroder US Smaller Companies Acc 0.69

Loomis Sayles Small Cap Growth Instl 0.68

Schroder ISF US S&M-Cap Eq C Acc USD 0.68

NeoGenomics, Inc. Market Status

Strong Buy: 6

Buy: 2

Hold: 6

Sell: 0

Strong Sell: 0

NeoGenomics, Inc. Fundamentals

Market Cap 1033.31 M

PB Ratio 1.2693

PE Ratio 0.0

Enterprise Value 1311.70 M

Total Assets 1359.83 M

Volume 3308944

NeoGenomics, Inc. Company Financials

Annual Revenue FY25:727332000 727.3M, FY24:660566000 660.6M, FY23:591643000 591.6M, FY22:509728000 509.7M, FY21:484329000 484.3M

Annual Profit FY25:282541000 282.5M, FY24:290100000 290.1M, FY23:244604000 244.6M, FY22:187896000 187.9M, FY21:187060000 187.1M

Annual Net worth FY25:-108025000 -108.0M, FY24:-78726000 -78.7M, FY23:-87968000 -88.0M, FY22:-144250000 -144.3M, FY21:-8347000 -8.3M

Quarterly Revenue Q4/2025:190170000 190.2M, Q3/2025:187797000 187.8M, Q2/2025:181330000 181.3M, Q1/2025:168035000 168.0M, Q4/2024:172000000 172.0M

Quarterly Profit Q4/2025:75711000 75.7M, Q3/2025:80446000 80.4M, Q2/2025:77258000 77.3M, Q1/2025:73246000 73.2M, Q4/2024:77257000 77.3M

Quarterly Net worth Q4/2025:-9881000 -9.9M, Q3/2025:-27129000 -27.1M, Q2/2025:-45092000 -45.1M, Q1/2025:-25923000 -25.9M, Q4/2024:-15324000 -15.3M

About NeoGenomics, Inc. & investment objective

Company Information NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Organisation Diagnostics & Research

Employees 2500

Industry Diagnostics & Research

CEO Mr. Anthony P. Zook

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NeoGenomics, Inc. FAQs

What is the share price of NeoGenomics, Inc. today?

The current share price of NeoGenomics, Inc. is $8.11.

Can I buy NeoGenomics, Inc. shares in India?

Yes, Indian investors can buy NeoGenomics, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy NeoGenomics, Inc. shares in India?

You can easily invest in NeoGenomics, Inc. shares from India by:

Can I buy fractional shares of NeoGenomics, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NeoGenomics, Inc.?

NeoGenomics, Inc. has a market cap of $1033.31 M.

In which sector does NeoGenomics, Inc. belong?

NeoGenomics, Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in NeoGenomics, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of NeoGenomics, Inc.?

The PE ratio of NeoGenomics, Inc. is N/A and the PB ratio is 1.27.